Heavy!

A few days ago, 8 departments including the State Food and Drug Administration jointly issued the "Fourteenth Five-Year Plan for National Drug Safety and Promotion of High-quality Development" (hereinafter referred to as the "Plan"), which clarified China’s drug safety and promotion of high-quality development during the "14th Five-Year Plan" period.

The "Plan" thoroughly implements the thought of socialism with Chinese characteristics in the new era of Jinping, implements the decisions and deployments of the Party Central Committee and the State Council, bases on the new development stage, implements the new development concept, builds a new development pattern, adheres to the people first, life first, and closely focuses on protecting drugs Safety, promote the high-quality development of drugs, promote the modernization of the drug regulatory system and regulatory capabilities, protect and promote the safety and health of the public's drug use, and propose major tasks and major projects

The "Plan" clarifies the main development goals during the "14th Five-Year Plan" period.

According to the development goals of the "14th Five-Year Plan", the "Plan" proposes to implement the whole-process supervision of drug safety, support industrial upgrading and development, improve the drug safety management system, continue to deepen the reform of the review and approval system, tighten vaccine supervision, and promote the inheritance and innovation of traditional Chinese medicine.

At the same time, the "Plan" puts forward the action plan for drug safety risk investigation, the national drug standard improvement action plan, the multi-sectoral collaborative policy toolbox for drug safety governance, speed up the construction of the review and approval system, improve the national adverse drug reaction monitoring system, and inspection and testing in the form of a column.

The "Plan" focuses on professional capacity building for review, inspection, inspection, monitoring and evaluation, and team building, and takes the drug regulatory system and regulatory capacity building as an important content

The "Plan" requires that it be necessary to strengthen the overall coordination and leadership of drug safety work, innovate and improve support and guarantee mechanisms, actively participate in global drug safety governance, and encourage drug regulatory cadres to perform their duties and perform their duties

By Man Xue, reporter of China Medical News